$Tharimmune (THAR.US)$ Reuters· just
Tharimmune: Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis

$Tharimmune (THAR.US)$
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update
Monday, 16th December at 8:00 am
BRIDGEWATER, NJ / ACCESSWIRE / December 16, 2024 / Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced plans for initiating a Phase 2 st...

$Tharimmune (THAR.US)$ This is interesting, good volumes observed on post market. Keep an eye on this.

$Crown Electrokinetics (CRKN.US)$ $Dermata Therapeutics (DRMA.US)$ $KORE Group (KORE.US)$ $Vivakor (VIVK.US)$ $Rent the Runway (RENT.US)$ $iCoreConnect (ICCT.US)$ $My Size (MYSZ.US)$ $Synaptogenix (SNPX.US)$ $Eupraxia Pharmaceuticals (EPRX.US)$ $Live Ventures (LIVE.US)$ $Worksport (WKSP.US)$ $Gaxos.ai (GXAI.US)$ $Tharimmune (THAR.US)$ $MEDIROM Healthcare Technologies (MRM.US)$
📊⚡️📊

$Tharimmune (THAR.US)$ offered at 2.03 and price hit 3.30 🤣🤣🤣

$Tharimmune (THAR.US)$
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs
Friday, 6th December at 4:15 pm
BRIDGEWATER, NEW JERSEY / ACCESSWIRE / December 6, 2024 / Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company committed to pioneering therapies in immunology and inflammation, today announced it has entered into a securities purchase agreement to raise gross proceeds of approximately $2.02 million throug...

$Tharimmune (THAR.US)$
Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease
Tharimmune (NASDAQ:THAR) presented Phase 1 clinical data for TH104 at AASLD The Liver Meeting 2024. The trial evaluated TH104 transmucosal buccal film in patients with chronic liver disease (CLD) for chronic pruritus treatment.
The study showed significant correlation between blood levels and symptom relief, with a correlation coeff...